Duboscq, C., Martinuzzo, M. E., Ceresetto, J., Lopez, M., Barrera, L., Oyhamburu, J., & Stemmelin, G. (2018). The fibrinogen prothrombin time‐derived method is not useful in patients anticoagulated with low molecular weight heparins or rivaroxaban. Journal of thrombosis and haemostasis, 16(8), 1626-1631. https://doi.org/10.1111/jth.14158
Citácia podle Chicago (17th ed.)Duboscq, C., M. E. Martinuzzo, J. Ceresetto, M. Lopez, L. Barrera, J. Oyhamburu, a G. Stemmelin. "The Fibrinogen Prothrombin Time‐derived Method Is Not Useful in Patients Anticoagulated with Low Molecular Weight Heparins or Rivaroxaban." Journal of Thrombosis and Haemostasis 16, no. 8 (2018): 1626-1631. https://doi.org/10.1111/jth.14158.
Citácia podľa MLA (8th ed.)Duboscq, C., et al. "The Fibrinogen Prothrombin Time‐derived Method Is Not Useful in Patients Anticoagulated with Low Molecular Weight Heparins or Rivaroxaban." Journal of Thrombosis and Haemostasis, vol. 16, no. 8, 2018, pp. 1626-1631, https://doi.org/10.1111/jth.14158.